These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

827 related articles for article (PubMed ID: 27108191)

  • 1. Effect of introduction of pentavalent vaccine as replacement for Diphtheria-Tetanus-Pertussis and Hepatitis B vaccines on vaccination uptake in a health facility in Nigeria.
    Sadoh AE; Nwaneri DU; Ogboghodo BC; Sadoh WE
    Vaccine; 2016 May; 34(24):2722-8. PubMed ID: 27108191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of adverse events following pentavalent and diphtheria-tetanus-pertussis vaccines among Nigerian children.
    Sadoh AE; Nwaneri DU; Ogboghodo BC; Sadoh WE
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):119-122. PubMed ID: 28585776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and yellow fever vaccines only. An observational study from Guinea-Bissau.
    Fisker AB; Ravn H; Rodrigues A; Østergaard MD; Bale C; Benn CS; Aaby P
    Vaccine; 2014 Jan; 32(5):598-605. PubMed ID: 24325827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timeliness of immunisation with the pentavalent vaccine at different levels of the health care system in the Lao People's Democratic Republic: A cross-sectional study.
    Hefele L; Syphan S; Xayavong D; Homsana A; Kleine D; Chanthavilay P; Nouanthong P; Xaydalasouk K; Phathammavong O; Billamay S; Xeuatvongsa A; Reinharz D; Black AP; Muller CP
    PLoS One; 2020; 15(12):e0242502. PubMed ID: 33290386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization coverage and risk factors for failure to immunize within the Expanded Programme on Immunization in Kenya after introduction of new Haemophilus influenzae type b and hepatitis b virus antigens.
    Ndiritu M; Cowgill KD; Ismail A; Chiphatsi S; Kamau T; Fegan G; Feikin DR; Newton CR; Scott JA
    BMC Public Health; 2006 May; 6():132. PubMed ID: 16707013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragmentation of scheduled visits and missed doses among infants receiving multiple injected vaccines.
    Ferson MJ; McKenzie KA; Macartney-Bourne F
    Aust N Z J Public Health; 1997 Dec; 21(7):735-8. PubMed ID: 9489191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timeliness of routine immunization in a population-based Italian cohort of very preterm infants: results of the ACTION follow-up project.
    Tozzi AE; Piga S; Corchia C; Di Lallo D; Carnielli V; Chiandotto V; Fertz MC; Miniaci S; Rusconi F; Cuttini M
    Vaccine; 2014 Feb; 32(7):793-9. PubMed ID: 24397902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infant vaccination timing: Beyond traditional coverage metrics for maximizing impact of vaccine programs, an example from southern Nepal.
    Hughes MM; Katz J; Englund JA; Khatry SK; Shrestha L; LeClerq SC; Steinhoff M; Tielsch JM
    Vaccine; 2016 Feb; 34(7):933-41. PubMed ID: 26788880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interchangeability of Quinvaxem during primary vaccination schedules: results from a phase IV, single-blind, randomized, controlled, single-center, non-inferiority study.
    Capeding MR; Jica C; Macura-Biegun A; Rauscher M; Alberto E
    Vaccine; 2014 Feb; 32(7):888-94. PubMed ID: 24176498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran.
    Teimouri F; Kebriaeezadeh A; Zahraei SM; Gheiratian M; Nikfar S
    Daru; 2017 Jan; 25(1):1. PubMed ID: 28088246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
    Vesikari T; Joensuu J; Baer M; Käyhty H; Olander RM; Sormunen H; Miettinen A; Ward RL; Guillot T
    Acta Paediatr; 1999 May; 88(5):513-20. PubMed ID: 10426173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination vaccine use and vaccination quality in a managed care population.
    Happe LE; Lunacsek OE; Marshall GS; Lewis T; Spencer S
    Am J Manag Care; 2007 Sep; 13(9):506-12. PubMed ID: 17803364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of a pentavalent combination vaccine on immunization timeliness in a state Medicaid population.
    Happe LE; Lunacsek OE; Kruzikas DT; Marshall GS
    Pediatr Infect Dis J; 2009 Feb; 28(2):98-101. PubMed ID: 19148039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the introduction of new vaccines in Guinea-Bissau on vaccine coverage, vaccine timeliness, and child survival: an observational study.
    Fisker AB; Hornshøj L; Rodrigues A; Balde I; Fernandes M; Benn CS; Aaby P
    Lancet Glob Health; 2014 Aug; 2(8):e478-87. PubMed ID: 25103521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of uptake of third doses of oral polio and DTP vaccines in the Ibadan North Local Government Area of Nigeria.
    Fatiregun AA; Etukiren EE
    Int Health; 2014 Sep; 6(3):213-24. PubMed ID: 24844557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B vaccination among children in inner-city public housing, 1991-1997.
    Lauderdale DS; Oram RJ; Goldstein KP; Daum RS
    JAMA; 1999 Nov; 282(18):1725-30. PubMed ID: 10568644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody persistence after a primary series of a new DTaP-IPV-Hep B-PRP-T combined vaccine or separate DTaP-IPV//PRP-T and hepatitis B vaccines at 2, 4, and 6 months of age and the effect of a subsequent DTaP-IPV//PRP-T booster vaccination at 18 months of age in healthy Argentinean infants.
    Tregnaghi M; Zambrano B; Santos-Lima E
    Pediatr Infect Dis J; 2012 Jan; 31(1):e24-30. PubMed ID: 22157567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
    Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
    Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new combined DTP-HBV-Hib vaccine--strategy for incorporation of Hib vaccination into childhood immunisation programmes.
    Ramkissoon A; Coovadia HM; Jugnundan P; Willems P; Clemens BR
    S Afr Med J; 2001 Oct; 91(10):864-9. PubMed ID: 11732460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.